FINAL REPORT DECISION MAKERS BACKGROUND INFORMATION AND RECOMMENDATIONS
|
|
- Carmella Wilson
- 6 years ago
- Views:
Transcription
1 Using Multidimensional Prognostic Indices to improve cost-effectiveness of interventions in multimorbid, frail older persons FINAL REPORT DECISION MAKERS BACKGROUND INFORMATION AND RECOMMENDATIONS
2 INTRODUCTION The MPI_AGE project is a research project co-funded by the European Union through the Health Programme that has explored ways to reduce unnecessary use of health care resources in older subjects through the design of appropriate, tailored, integrated, multi-professional, planned interventions. This project opted to use a well-validated diagnostic and prognostic tool, the Multidimensional Prognostic Index (MPI), based on a standard Comprehensive Geriatric Assessment (CGA), and analyzed how it can improve the cost-effectiveness of health interventions in complex older individuals with multimorbidity and polypharmacy. To do so, a review analysis on the use of predictive rules in clinical and management decision making in older residents in different European regions has been performed to identify reference models to allocate resources and lower costs in healthcare. Analyses of multi-national databases including information on drug prescriptions and older subjects characteristics have identified some setting-specific MPI-profiles in which individual interventions are more cost-effective in terms of improved survival. The aims of the MPI_AGE project were to: OBJECTIVES identify the most cost-effective health interventions according to the individual prognostic mortality-risk profile; improve multi-professional interactions and collaboration in performing integrated care pathways of interventions according to the individual MPI-risk profile; develop tailored intervention programs based on the individual MPI-profile of older subjects; explore ways to reduce health-related costs, linked to a reduction of hospitalization rates, in-hospital length-of stay, institutionalization rates, and inappropriate and unnecessary prescription drug use.
3 PARTNERS OF MPI_AGE The MPI_AGE project involves the following centers and organizations in twelve different countries. ASSOCIATE PARTNERS Italy: AULSS16 - Azienda Unità Locale Socio Sanitaria nº 6 Euganea, Padova (Coordinating center) Czech Republic: Univerzita Karlova, Prague France: CHU, Poitiers Germany: Universitätsklinikum Köln, Cologne Netherlands: Erasmus Universitair Medisch Centrum, Rotterdam Spain: Fundación Para la Investigación Biomédica del Hospital Universitario Ramon y Cajal, Madrid Sweden: Karolinska Institute, Stockholm Europe: European Union Geriatric Medicine Society (EUGMS) COLLABORATING PARTNERS Australia: Flinders University, Adelaide Belgium: EUREGHA; AGE platform Europe Bulgaria: Bulgaria Association on Ageing Estonia: Estonian Association of Gerontology Italy: Regione del Veneto - Servizio per le relazioni socio-sanitarie; Centro Regionale Management Progetti Europei CReMPE; National Research Council CNR; IRCCS Casa Sollievo della Sofferenza; Università degli Studi di Messina; E.O. Ospedali Galliera di Genova Hungary: Semmelweiss University, Budapest United States of America: National Institute on Aging; John Hopkins Bloomberg School of Public Health
4 THE MULTIDIMENSIONAL PROGNOSTIC INDEX (MPI) MPI is a prognostic tool based on a standard CGA that has been shown to predict short- and long-term survival in older subjects, as well as other negative health outcomes (hospitalization, nursing home admission, length of hospital stay). The MPI includes information in 8 domains of CGA as follows: 1. Activities of Daily Living (ADL): 6 items 2. Instrumental Activities of Daily Living (IADL): 8 items 3. Short Portable Mental Status Questionnaire (SPMSQ): 10 items 4. Mini Nutritional Assessment (MNA): 18 items 5. Exton-Smith Scale (ESS): 5 items 6. Cumulative Index Rating Scale Comorbidity Index (CIRS-CI): 14 items 7. Number of drugs used: 1 item 8. Co-habitation status: 1 item To obtain the final index of a given individual, a program calculates a MPI score, which ranges from 0 to 1. This calculation can be easily performed by a program that can be downloaded at no cost ( or using an IOS free app (impi). The MPI index predicts mortality lower values are associated with lower mortality. Usually, results are ranked in three levels: 0 to 0.33 low mortality risk, MPI to 0.66 moderate mortality risk, MPI to 1 high mortality risk, MPI 3 Studies have shown that MPI values predict short and long-term mortality in older subjects. The prognostic accuracy of the aggregated MPI is significantly greater than the prognostic accuracy of its individual components considered singularly. Thus, this multidimensional approach can be successfully used in older patients for both clinical and administrative purposes.
5 DEVELOPMENT AND VALIDATION OF THE MPI A cluster analysis on CGA data was made to identify independent domains and variables of CGA that predicted mortality. Following a step-wise method, other domains of the CGA were progressively included in the model in order to obtain the best combination of different CGA domains for the best prognostic accuracy. Clinical results have confirmed that MPI has a good prognostic effect on short- and long-term mortality, with a close agreement between the estimated and the observed mortality. The MPI has been validated in geriatric complex patients, and also in older patients affected with several acute and chronic diseases such as gastrointestinal bleeding, pneumonia, heart failure, dementia, liver cirrhosis, chronic kidney disease and transient ischemic attack. The MPI has been validated in hospitalized older people, community-dwelling older (to establish accessibility to nursing homes or homecare services, and healthy older people). Many clinical studies and recent meta-analyses and systematic reviews report that the MPI has high accuracy, excellent calibration, and the highest validity, reliability and feasibility compared to others tools used to identify frail older patients both in clinical practice and in research. MPI-SVAMA The MPI-SVAMA index is an evolution of the MPI. This version obtains information from SVAMA (Scheda per la Valutazione Multidimensionale delle persone adulte e Anziane), a standardized CGA used in the Veneto Region (Italy) to grant access to health and social care. The MPI-SVAMA index is calculated from the following nine domains: 1. Age (years) 2. Gender 3. Nursing care: 11 items 4. Exton-Smith scale: 5 items 5. Short Portable Mental Status Questionnaire: 10 items 6. Activities of Daily Living: 6 items 7. Functional mobility (mobility items of Barthel scale): 3 items 8. Social network: 1 item 9. Main medical diagnosis MPI-SVAMA was built using information from SVAMA of a population of more than 7,800 older people aged 65 years old living at home, and validated on a separate population of over 4,000 older subjects, using 1-month and 1-year mortality as outcomes. This index can be calculated with the use of a free program ( and also ranges from 0 to 1. However, cut-off points used to rank MPI-SVAMA are different and time dependent. For short term mortality (1 month): For long term mortality (1 year): 0 to 0.41 low mortality risk, MPI 1 0 to 0.33 low mortality risk, MPI to 0.53 moderate mortality risk, MPI to 0.47 moderate mortality risk, MPI to 1 high mortality risk, MPI to 1 high mortality risk, MPI 3
6 CORE ACTIVITIES OF MPI_AGE A. Analysis on the use of predictive rules in clinical decision making in community-dwelling older people. An analysis on the use of predictive rules (MPI) in clinical and management decision-making in community-dwelling older subjects was performed using clinical, functional and administrative data included in large databases from different European regions. Population-based cohort databases containing data on large populations are potentially an accurate source in predicting multidimensional impairment and frailty in heterogeneous groups of older persons in terms of short- and long-term mortality and other negative health outcomes. This is important for appropriate health care planning. We explored the adaptation of MPI to be used in large databases in order to classify patients to improve decision making. Multidimensional Prognostic Index in community dwelling older healthy people The application of MPI in 2,472 older residents in Stockholm (Sweden) included in the Swedish National Study on Aging and Care (SNAC-K) demonstrated a clear and significant association between MPI score and survival time and risk of hospitalization. Higher MPI risk scores were associated with more days in hospital and with fewer years of survival across a broad and stratified age range (65-74 years, years, > 84 years) in this population based setting with a very long-term follow-up (up to 12 years). This is the first study that confirms the prognostic value of MPI in a population-based cohort. Multidimensional Prognostic Index in community dwelling older people with dementia Previous studies showed that MPI accurately stratified hospitalized older patients with dementia into groups at varying risk of short- and long-term mortality. Also, MPI was shown to predict the risk of hospitalization in outpatients with cognitive impairment and dementia. Moreover, the MPI has been used as a valid outcome measure in an intervention trial in patients with Alzheimer s disease. In MPI_AGE, a cohort of 6,800 community-dwelling older persons with dementia were identified in a database of almost 23,000 community-dwelling older residents in Veneto Region (Italy) who applied to homecare services or nursing home admission. In this population, MPI strongly predicted 3-year mortality. When stratified according to MPI-defined strata, after adjustment for covariables, the use of drugs for dementia (anti-cholinesterase inhibitors and/or memantine) was associated with lower mortality in subjects with MPI-defined low-risk (HR %CI , p<0.01) and moderate-risk (HR 0.61, 95%CI , p<0.01), but not in those with high-risk of mortality (HR 1.04, 95%CI ). These results show that MPI may be useful to make recommendations on treatments in Alzheimer s disease patients.
7 CORE ACTIVITIES OF MPI_AGE B. Use of MPI to improve cost-effectiveness of drug treatments in older people with multimorbidity and polypharmacy. MPI was used to identify the effectiveness of different drugs across different levels of frailty and dependence in large multinational databases. Multidimensional Prognostic Index in a general practice database MPI_AGE explored the usefulness of data included in the THIN database (this database collects information on almost 1,200,000 subjects followed-up by their General Practitioners in the United Kingdom). It was found that multidimensional indicators were not frequently recorded in the THIN database, so a full MPI could not be obtained. However, the accuracy of a model incorporating age, sex, and available functional and cognitive measures was able to predict 1-month and 1-year mortality among community-dwelling older people. The use of such indicators in GP database reflects a newer approach, which may improve mortality prediction among older persons in clinical practice. Expanding the adaptation of MPI or MPI principles to other large databases may be helpful to better classify patients in order to tailor resource use. Multidimensional Prognostic Index and the care of frail older people: where evidence is lacking Frail subjects are usually excluded from clinical trials, so clinical guidelines give little insight on how to treat frequent problems in geriatric complex patients. This fact frequently leads to potentially inappropriate under- or over-utilization of drugs and interventions, increasing the risk of adverse drug reactions and reducing the efficiency of use of scarce resources. The use of MPI to better understand risks and benefits of drug treatments in this population was explored in two areas in which evidence is still lacking and the risk-benefit ratios are unclear: the use of statins and anticoagulation therapies in very old, high-risk, frail subjects. First, in the database of almost 23,000 community-dwelling older residents in Veneto Region (Italy), 1,712 subjects with diabetes mellitus (mean age=81.1±7.3 years, males = 43%) were selected. By using the clinical stratification according to the MPI, it was shown that statin treatment was significantly associated with reduced three-year mortality independently of age and multidimensional impairment in this population. A second population of 2,597 patients with coronary artery disease was also analyzed (mean age=84±7.3 years, males = 44.5%), again showing that statin treatment was significantly associated with reduced three-year mortality independently of age and MPI score, although the frailest were less likely to be treated with statins. Put together, these finding are reassuring of the use of statins in old, complex patients that were excluded from trials but are already using such drugs. Finally, a study of 1,827 community-dwelling older persons with atrial fibrillation classified by the MPI in three grades of risk demonstrated a benefit of anticoagulation in terms of lower all-cause mortality over a mean follow-up of 2 years, regardless of poor health and functional conditions. Interaction tests showed that reduction of mortality with anticoagulants was higher in subjects with severe complexity (higher MPI score). Multidimensional Prognostic Index and invasive procedures An additional relevant topic in geriatric medicine is the appropriate selection of older patients who can benefit from interventions with invasive therapeutic procedures. To explore the use of MPI in this clinical setting, a prospective observational study was carried out in consecutive patients aged 75 years who underwent transcatheter aortic valve implantation (TAVI). MPI was calculated at baseline. A follow-up time of 1-year was performed. Among the 116 patients included (mean age 86.2±4.2 years, mean MPI score 0.39±0.13), mortality rate was significantly different between MPI groups at 6 and 12 months (p=0.04 and p=0.02). Kaplan Meier survival estimates at 1-year stratified by MPI groups were significantly different (HR=2.83, 95% CI , p=0.004). The study indicated that CGA-based MPI was an accurate tool to predict prognosis and select older patients for TAVI procedures.
8 CORE ACTIVITIES OF MPI_AGE C. Use of MPI to improve resource allocation in older hospitalized persons. A large multicenter clinical trial was performed to analyze the role of MPI in the identification of hospitalized patients with different characteristics and needs, which were prospectively followed for 1 year. In the last years, great attention has been given to the proper identification of prognosis to help clinical decision-making to tailor appropriate diagnostic and treatment interventions for frail older patients. It is now well known that adding functional, cognitive, nutritional and social data improves prognostic tools that are only based on an index disease, so multidimensional tools should be useful to better quantify the prognosis of frail older subjects. However, a large systematic review identified, after searching over 20,000 references, a very small number of validated prognostic indices for mortality that meet the necessary requirements of accuracy and calibration required to be used in a clinical setting, i.e. eight indices for hospitalized older patients, two for those living in nursing homes, and six for community-dwellers. Among the eight indices studied in hospital settings, MPI was the only CGA-based predictive tool. MPI is well-calibrated and has a good discrimination properties and accuracy in predicting mortality both at short-term (1 month) and long-term (1 year). Very recently, a systematic review reported that MPI had the highest validity, reliability and feasibility (i.e. score 14 - maximum value - on the QUADAS system), compared to other tools used to identify frail older patients. MPI has been used in several multi-center studies in Italy to predict prognosis in hospitalized, frail older individuals. For example, in a prospective multicenter study involving over 2,000 hospitalized older patients in 20 different hospitals, MPI was a significantly more accurate predictor of short- and long-term all-cause mortality than other three frailty indices commonly used in clinical practice including FI-CGA and SOF. Other prospective multicenter studies demonstrated that MPI was an independent predictor of in-hospital mortality and of length of hospital stay in such populations. Moreover, during hospitalization MPI score changed in most of patients (overall, the MPI score improved in 35.3% and worsened in 26.6% of patients, these changes were gender and age-related) and therefore MPI might be used to objectively track and monitor the clinical evolution of acutely ill older patients admitted to the hospital. The MPI_AGE multicenter trial Based on these findings, the MPI_AGE project evaluated prospectively 1,148 hospitalized patients recruited in 9 international centers across Europe and Australia (mean age 84.4±8.8 years, females = 61%) and classified them according to the MPI score at admission and at discharge from the hospital. Patients were followed for one year. Results of this prospective multicenter international study confirmed that MPI at hospital admission significantly predicts in-hospital mortality (MPI-1 HR =1.0 [reference], MPI-2 HR=3.0, 95%CI , MPI-3 HR=10.4, 95%CI ) with good accuracy (area under the curve- AUC=0.76, p<0.001) and MPI at hospital discharge significantly predicts 1-year mortality (MPI-1 HR =1.0 [reference], MPI-2 HR=2.4, 95%CI , MPI-3 HR=12.1, 95%CI: ), again with good accuracy (AUC 0.77). Moreover, MPI class on admission was significantly predictive of length-of-hospital stay (LOS), i.e. MPI 1= 7.9±5.6 days vs MPI 2= 13.5±10.2 days vs MPI 3= 16.5±13.6 days (data adjusted for age, gender, hospital and diagnosis at discharge).
9 CORE ACTIVITIES OF MPI_AGE In this population, MPI significantly changed during hospitalization in most of patients, improving in 35% and worsening in 27% of them. Interestingly, an improvement of MPI during hospitalization was associated with a significant reduction in mortality at 1 year (HR=0.65, 95%CI , p=0.004). In addition, MPI worsening was significantly associated with a 54% increase in the use of home-services (HR 1.54, 95%CI , p=0.01) (data adjusted for MPI at admission, age, gender, hospital, LOS and diagnosis at discharge). Diagnostic tests used during hospitalization have been classified according to MPI value. Older patients with higher MPI values were more often diagnosed using X-Ray tests (MPI-1 54% vs MPI-2 55% vs MPI-3 61%, p=0.006) and less using ultrasonography (MPI % vs MPI % vs MPI %, p=0.01) or endoscopy (MPI-1 5.0% vs MPI-2 3.5% vs MPI-3 3.7%, p=0.02). No differences were observed in the use of CT, MRI or nuclear medicine diagnostic tests. During the one-year follow-up period, MPI grade was also significantly associated with the use of home-care services (MPI-1 Odds Ratio 1.0 reference; MPI-2 OR 2.47, 95%CI , MPI-3 OR 1.82, 95%CI , p=0.002) and with admission to nursing homes (MPI-1 OR 1.0 reference; MPI-2 OR 2.2, 95%CI , MPI-3 OR 1.7, 95%CI , p=0.002). Along the one-year follow-up, 606 out of 1,140 patients (53.1%) were re-hospitalized. One-year re-hospitalization was significantly associated with all-cause mortality (HR=1.79, 95%CI , p<0.001). Moreover, one-year re-hospitalization was significantly associated with higher MPI grade (MPI-1 Odds Ratio: 1.0 reference; MPI-2 OR 1.69, 95%CI , MPI-3 OR 1.60, 95%CI ), lower age (OR=0.98, 95%CI ), male gender (OR: 1.29, 95%CI ) and the hospital center (OR: 0.91, 95%CI ).
10 MPI_AGE RECOMMENDATIONS AND CONCLUSIONS Health interventions should be adapted to individual needs of older patients, especially for those with high disease burden, high complexity or relevant major physical and mental impairments. Individual needs should be objectively assessed by means of validated instruments. These instruments should be multidimensionalt o capture all aspects that are relevant for each person. Objective assessment of needs may avoid discrimination of older people (ageism) in decision-making. The Multidimensional Prognostic Index (MPI) has proved to be the best validated assessment instrument in various healthcare settings (community, hospital and nursing homes) and across a wide range of diseases and conditions. MPI also identifies problems in several domains that may benefit from specialist comprehensive geriatric care. Tailored healthcare interventions have the potential to reduce the inappropriate use of resources (hospitalizations, drugs, diagnostic and other procedures) and to allow well-established treatments and interventions to be used in older people who can benefit from them. Tailored healthcare interventions have the potential to reduce inappropriate health-related costs, making health care services more efficient. MPI can be adapted for use in population-based (Primary Care) and diseaseoriented databases to accurately predict survival and other health outcomes. This can be helpful in order to plan resource deployment and allocation. In hospitalized older persons MPI identifies groups at risk for several hospital outcomes (i.e. mortality, length of stay, use of diagnostic tests). Individuals within each risk group may benefit from the adaptation of interventions to his/her prognosis and needs. In hospitalized older persons MPI predicts several post-discharge outcomes (one-year mortality, rehospitalisation, admission to a nursing home, use of home-care services).
11 REFERENCES Angleman SB, Santoni G, Pilotto A, Fratiglioni L, Welmer AK on behalf of the MPI_AGE Project Investigators. Multidimensional Prognostic Index in association with future mortality and number of hospital days in a population-based sample of older adults: results of the EU funded MPI_AGE Project. PLoS One 2015;10:e Brunello A, Fontana A, Zafferri V et al. Development of an oncological-multidimensional prognostic index (Onco-MPI) for mortality prediction in older cancer patients. J Cancer Res Clin Oncol May;142(5): Bureau ML, Liuu E, Christiaens L et al. on behalf of the MPI_AGE Project Investigators. Using a multidimensional prognostic index (MPI) based on comprehensive geriatric assessment (CGA) to predict mortality in elderly undergoing transcatheter aortic valve implantation. Int J Cardiol Jun 1; 236: D Onofrio G, Sancarlo D, Addante F et al. A pilot randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer s disease. Int J Geriatr Psych 2015;30: Daragjati J, Musacchio C, Polidori MC et al. on behalf of the MPI_AGE Investigators. Multidimensional Prognostic Index in hospitalized elderly patients across Europe and Australia: a prospective multicenter study of the European MPI_AGE project. Eur Geriatr Med 2016; 7(S1):S16. Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: a review. Eur J Int Med 2016;31:3-10. Fontana L, Addante F, Copetti M et al. Identification of a metabolic signature for multidimensional impairment and mortality risk in hospitalized older patients. Aging Cell (3): Gallucci M, Battistella G, Bergamelli C, et al. Multidimensional Prognostic Index in a cognitive impairment outpatient setting: mortality and hospitalizations. The Treviso Dementia (TREDEM) Study. J Alzheimer s Dis 2014;42: Giantin V, Valentini E, Iasevoli M et al. Does the Multidimensional Prognostic Index (MPI), based on a Comprehensive Geriatric Assessment (CGA), predict mortality in cancer patients? Results of a prospective observational trial. J Geriatr Oncol 2013; 4: Giantin V, Falci C, De Luca E et al. Performance of the Multidimensional Geriatric Assessment and Multidimensional Prognostic Index (MPI) in predicting negative outcome in older adults with cancer. Eur J Cancer Care 2016 Oct 10; doi: /ecc [Epub ahead of print]. Gill TM. The central role of prognosis in clinical decision making. JAMA 2012; 307: Mangoni AA, Pilotto A. New drugs and patient-centred end-points in old age: setting the wheels in motion. Expert Rev Clin Pharmacol 2016; 9 (1): Pilotto A, Ferrucci L, Franceschi M, et al. Development and validation of a multidimensional prognostic index for 1-year mortality from the comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res 2008;11: Pilotto A, Addante F, D Onofrio G, Sancarlo D, Ferrucci L. The Comprehensive Geriatric Assessment and the multidimensional approach. A new look at the older patient with gastroenterological disorders. Best Pract Res Clin Gastroenterol 2009;23: Pilotto A, Addante F, Ferrucci L et al. The Multidimensional Prognostic Index (MPI) predicts short and long-term mortality in older patients with community-acquired pneumonia. J Gerontol A Biol Med Sci 2009;64: Pilotto A, Sancarlo D, Panza F, et al. The Multidimensional Prognostic Index (MPI) based on a Comprehensive Geriatric Assessment predicts short- and long-term mortality in hospitalized older patients with dementia. J Alzheimer s Dis 2009;18: Pilotto A, Addante F, Franceschi M et al. A Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short-term mortality in older patients with heart failure. Circ Heart Fail 2010; 3: Pilotto A, Sancarlo D, Franceschi M et al. A multidimensional approach to the geriatric patient with chronic kidney disease. J Nephrol 2010; 23: S5-10. Pilotto A, Rengo F, Marchionni N, Sancarlo D, Fontana A, Panza F, Ferrucci L on behalf of the FIRI-SIGG Study group. Comparing the prognostic accuracy for all-cause mortality of the Frailty Instruments: a multicentre 1-year follow-up in hospitalized older patients. PLosOne 2012; 7(1): e29090 (1-9). Pilotto A, Panza F, Ferrucci L. A Multidimensional Prognostic Index in Common Conditions Leading to Death in Older Patients. Arch Intern Med 2012; 172 (7): Pilotto A, Gallina P, Fontana A, et al. Development and validation of a multidimensional prognostic index for mortality based on a standardized Multidimensional Assessment Schedule (MPI-SVaMA) in community-dwelling older subjects. J Am Med Dir Assoc 2013;14: Pilotto A, Sancarlo D, Polidori MC on behalf of the MPI_ AGE Investigators. The MPI_AGE European Project: Using Multidimensional Prognostic Indices (MPI) to improve cost-effectiveness of interventions in multimorbid frail older persons. Background, aim and design. Eur Geriatr Med 2015;6: Pilotto A, Panza F, Copetti M, et al. on behalf of the MPI_AGE Project Investigators. Statin treatment and mortality in community-dwelling frail older patients with diabetes mellitus: a retrospective observational study. PLoS One 2015;10:e Pilotto A, Arboretti GR, Panza F et al. on behalf of the MPI_AGE Investigators. Role of anti-dementia drugs and multidimensional impairment on mortality rates in frail multimorbid older patients with dementia: results from the European MPI_AGE project. 11th Congress of the EUGMS (European Union Geriatric Medicine Society), Oslo, Norway, September Eur Geriatr Med 2015; 6(S1): S20. Pilotto A, Sancarlo D, Rengo F, et al. on behalf of the FIRI SIGG Study Group. The Multidimensional Prognostic Index predicts in-hospital length of stay in older patients: a multicenter prospective study. Age Ageing 2016;45: Pilotto A, Gallina P, Copetti M et al. on behalf of the Multidimensional Prognostic Index_Age Project Investigators. Warfarin Treatment and All-Cause Mortality in Community-Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study. J Am Geriatr Soc 2016 Jul;64(7): Pilotto A, Gallina P, Panza F, et al. on behalf of the Multidimensional Prognostic Index_Age Project Investigators. Relation of statin use and mortality in community-dwelling frail older patients with coronary artery disease Am J Cardiol Dec;118(11): Pilotto A, Cella A, Pilotto A et al. Three decades of Comprehensive Geriatric Assessment: evidence coming from different healthcare settings and specifric clinical conditions. J Am Med Dir Assoc. 2017; 18(2):192.e1-192.e11. Sancarlo D, D Onofrio G, Franceschi M et al. Validation of a modified Multidimensional Prognotic Index (m-mpi) including the Mini Nutritional Assessment Short-form (MNA-SF) for the prediction of one-year mortality in hospitalized elderly patients. J Nutr Health Aging 2011; 15: Sancarlo D, Pilotto A, Panza F et al. A Multidimensional Prognostic Index (MPI) based on a Comprehensive Geriatric Assessment predicts short- and long-term all-cause mortality in hospitalized older patients with Transient Ischemic Attach. J Neurol 2012; 259: Siontis GC, Tzoulaki I, Ioannidis JP. Predicting death: an empirical evaluation of predictive tools for mortality. Arch Intern Med 2011; 171: Sultana J, Basile G, Trifirò G. Measuring frailty in population-based healthcare databases: multi-dimensional prognostic indices for the improvement of geriatric care. Geriatric Care 2016; 2: Sultana J, Fontana A, Giorgianni F, et al. Multidimensional frailty indicators in a nationwide GP database predict mortality in the elderly: MPI_AGE results. 11th Congress of the EUGMS (European Union Geriatric Medicine Society), Oslo, Norway, September Eur Geriatr Med 2015;6(S1):S23. Volpato S, Bazzano S, Fontana A, Ferrucci L, Pilotto A on behalf of the MPI-TriVeneto Study Group. Multidimensional Prognostic Index predicts mortality and length of stay during hospitalization in the older patients: a multicenter prospective study. J Gerontol A Biol Sci Med Sci 2015; 70 (3): Volpato S, Daragjati J, Simonato M, et al. Change in the multidimensional prognostic index score during hospitalization in older patients. Rejuvenation Res 2016;19: Warnier RMJ, Van Rossum E, Van Velthuijsen E, et al. Validity, reliability and feasibility of tools to identify frail older patients in inpatient hospital care: a systematic review. J Nutr Health Aging 2016;20:218-3 Yourman LC, Lee SJ, Schonberg MA, Widera EW, Smith AK. Prognostic indices for older adults: a systematic review. JAMA 2012; 307:
12 LEAD PARTNER AULSS 6 Euganea Padova Via E. degli Scrovegni, Padova Italy Website: geriatria.osa@aulss6.veneto.it COMMUNICATION LEADER EUGMS - European Geriatric Medicine Society Secretariat Vienna - Laudongasse, 21/ Vienna Austria secretariat@eugms.org PROJECT LEADER Dr. Alberto Pilotto - E.O. Galliera Hospital Mura delle Cappuccine, Genova Italy alberto.pilotto@galliera.it WEB & MEDIA
FINAL REPORT GENERAL PUBLIC BACKGROUND INFORMATION AND RECOMMENDATIONS
Using Multidimensional Prognostic Indices to improve cost-effectiveness of interventions in multimorbid, frail older persons FINAL REPORT GENERAL PUBLIC BACKGROUND INFORMATION AND RECOMMENDATIONS INTRODUCTION
More informationTable Of Content. Outputs... 7
Table Of Content Using Multidimensional Prognostic Indices(MPI)to improve costeffectiveness of interventions in multimorbid frail older persons.... 2 Summary... 3 Coordinator, Leader contact and partners...
More informationWork Package 4 Analysis on the use of predictive rules in clinical decision making in community - dwelling older people.
Work Package 4 Analysis on the use of predictive rules in clinical decision making in community - dwelling older people. Deliverable n. 7 Analysis report on the use of predictive rules in clinical decision
More informationGeriatric screening tools in older patients with cancer
Geriatric screening tools in older patients with cancer Pr. Elena Paillaud Henri Mondor hospital, Créteil, France University Paris-Est Créteil CONFLICT OF INTEREST DISCLOSURE I have the following potential
More informationWork package 5 Using MPI to improve cost effectiveness of drug treatmens in the olders with multimorbidity and polipharmacy
Work package 5 Using MPI to improve cost effectiveness of drug treatmens in the olders with multimorbidity and polipharmacy Deliverable n. 8 Report on the use of CGA based MPI in improving cost effectiveness
More informationAssessing older patients with hematological malignancies
Assessing older patients with hematological malignancies Alfonso J. Cruz Jentoft Servicio de Geriatría Hospital Universitario Ramón y Cajal Madrid, Spain Is old = frail? 45 days old 2,000 years old 4,600
More informationComparing the Prognostic Accuracy for All-Cause Mortality of Frailty Instruments: A Multicentre 1-Year Follow-Up in Hospitalized Older Patients
Comparing the Prognostic Accuracy for All-Cause Mortality of Frailty Instruments: A Multicentre 1-Year Follow-Up in Hospitalized Older Patients Alberto Pilotto 1,2 *, Franco Rengo 3,4, Niccolò Marchionni
More informationNon-commercial use only
Italian Journal of Medicine 2015; volume 9:120-124 Complexity of patients with chronic obstructive pulmonary disease hospitalized in internal medicine: a survey by FADOI Carlo Nozzoli, 1 Luigi Anastasio,
More informationAll about interrai. Len Gray Coordinator, interrai Network of Excellence in Acute Care April
All about interrai Len Gray Coordinator, interrai Network of Excellence in Acute Care April 2014 The interrai research collaborative Australia Belgium Canada Chile China Czech Republic Denmark Estonia
More informationTable Of Content. Appropriate care paths for frail elderly patients: a comprehensive model... 2 Summary... 3 Work Package... 7
Table Of Content Appropriate care paths for frail elderly patients: a comprehensive model... 2 Summary... 3 Work Package... 7 Coordination of the project... 7 Dissemination of the project... 7 Evaluation
More informationJAMDA 14 (2013) 53e57 JAMDA. journal homepage:
JAMDA 14 (2013) 53e57 JAMDA journal homepage: www.jamda.com Original Study Body Mass Index as a Predictor of All-Cause Mortality in Nursing Home Residents During a 5-Year Follow-up Nicola Veronese MD a,
More informationTable Of Content. A European Network of Centres of Reference for Dysmorphology... 2 Summary... 3 Coordinator, Leader contact and partners...
Table Of Content A European Network of Centres of Reference for Dysmorphology... 2 Summary... 3 Coordinator, Leader contact and partners... 4 The Children's Memorial Health Institute IPCZD... 4 Katholieke
More informationThe Geriatrician in the Trauma Service. Trauma Quality Improvement Program (TQIP) Annual Scientific Meeting and Training 2013
The Geriatrician in the Trauma Service Trauma Quality Improvement Program (TQIP) Annual Scientific Meeting and Training 2013 Challenges of the Geriatric Trauma Patient Challenges of the Geriatric Patient
More informationPolymedication in nursing home. Graziano Onder Centro Medicina dell Invecchiamento Università Cattolica del Sacro Cuore Rome - Italy
Polymedication in nursing home Graziano Onder Centro Medicina dell Invecchiamento Università Cattolica del Sacro Cuore Rome - Italy Services and Health for Elderly in Long TERm care (SHELTER) 4156 residents
More informationEuropean Collaboration on Dementia. Luxembourg, 13 December 2006
European Collaboration on Dementia Luxembourg, 13 December 2006 2005 Call for projects Special attention has also to be given to information and definition of indicators on neurodegenerative, neurodevelopment,
More informationEIP-AHA A3 Action Group F2F Meeting SUNFRAIL Preliminary Results
EIP-AHA A3 Action Group F2F Meeting SUNFRAIL Preliminary Results University of Valencia Emilia-Romagna Region Mirca Barbolini Marcello Maggio & SUNFRAIL TEAM Valencia, 29 th. June 2017 SUNFRAIL Project
More informationThe health economic landscape of cancer in Europe
1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor
More informationPre- Cardiac intervention. Dr. Victor Sim 26 th Sept 2014
Pre- Cardiac intervention Frailty assessment Dr. Victor Sim 26 th Sept 2014 Defining frailty Lacks consensus (Rockwood CMAJ 2005;173(5):489-95 Introduction) Some consider symptoms, signs, diseases and
More informationGSK Medicine: Study Number: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationThe Long-term Prognosis of Delirium
The Long-term Prognosis of Jane McCusker, MD, DrPH, Professor, Epidemiology and Biostatistics, McGill University; Head, Clinical Epidemiology and Community Studies, St. Mary s Hospital, Montreal, QC. Nine
More informationEarly release, published at on June 8, Subject to revision.
CMAJ Early release, published at www.cmaj.ca on June 8, 215. Subject to revision. Research External validation of the Hospital-patient One-year Mortality Risk (HOMR) model for predicting death within 1
More informationManagement of the Frail Older Patients: What Are the Outcomes
Management of the Frail Older Patients: What Are the Outcomes Professor Edwina Brown Imperial College Renal and Transplant Centre Hammersmith Hospital, London Increasing prevalence of old old on RRT RRT
More informationAcute care for older people with frailty
Acute care for older people with frailty Professor Simon Conroy Clinical lead, Acute Frailty Network, England Geriatrician, University Hospitals of Leicester Worldview that will colour this talk Demography
More information4/26/2012. Laura Grooms, MD Assistant Professor Geriatric Medicine Department of Family and Geriatric Medicine University of Louisville April 20, 2012
Laura Grooms, MD Assistant Professor Geriatric Medicine Department of Family and Geriatric Medicine University of Louisville April 20, 2012 Laura Grooms, MD Assistant Professor Geriatric Medicine Department
More informationDrug use in long term care. Graziano Onder Centro Medicina Invecchiamento Università Cattolica Sacro Cuore, Rome
Drug use in long term care Graziano Onder Centro Medicina Invecchiamento Università Cattolica Sacro Cuore, Rome Polypharmacy in nursing home (USA) Concurrent use of 9 medications was reported for 39.7%
More informationTHE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures
THE CVD CHALLENGE IN NORTHERN IRELAND Together we can save lives and reduce NHS pressures The challenge of CVD continues today. Around 225,000 people in Northern Ireland live with the burden of cardiovascular
More informationEIP AHA Valencia 2016 Towards an Active and Healthy Ageing. Emilia-Romagna Region - Reference Site EIP-AHA
EIP AHA Valencia 2016 Towards an Active and Healthy Ageing Emilia-Romagna Region - Reference Site EIP-AHA A Regional Model to Predict Identify and Manage Multimorbidity and Frailty Mirca Barbolini Valencia
More informationWork package 6, task 2: Review existing care (pathway) approaches for multi-morbidity patients
Work package 6, task 2: Review existing care (pathway) approaches for multi-morbidity patients Mieke Rijken Petra Hopman Janneke Noordman Franςois Schellevis Two activities:.. provide an overview of integrated
More informationNutritional Assessment in frail elderly. M. Secher, G.Abellan Van Kan, B.Vellas 1st December 2010 Firenze
Nutritional Assessment in frail elderly M. Secher, G.Abellan Van Kan, B.Vellas 1st December 2010 Firenze Frailty definition Undernutrition as part of the frailty syndrome Nutritional assessment in frail
More informationpublic health crisis! Understanding frailty at population level!
Frailty as an emerging public health crisis! Understanding frailty at population level! Dr Rónán O Caoimh, MB, MRCPI, MSc, PhD Senior Lecturer in Geriatric Medicine 08/03/2017 A brief history of frailty...
More informationThe COLLaboration on AGEing (COLLAGE)
The COLLaboration on AGEing (COLLAGE) Professor D. William Molloy University College Cork, Ireland. The Lessons from Europe Seminar 23-09-15 Overview Exemplars within COLLAGE: 1. What is COLLAGE? 2. The
More informationi-abc - Inhaled antibiotics in bronchiectasis and cystic fibrosis
PROYECTOS EUROPEOS EN LOS QUE PARTICIPA EL IRYCIS Innovative Medicines Initative i-abc - Inhaled antibiotics in bronchiectasis and cystic fibrosis http://www.imi.europa.eu/content/iabc Start Date: 01/08/2015
More informationThe Korean version of the FRAIL scale: clinical feasibility and validity of assessing the frailty status of Korean elderly
ORIGINAL ARTICLE Korean J Intern Med 2016;31:594-600 The Korean version of the FRAIL scale: clinical feasibility and validity of assessing the frailty status of Korean elderly Hee-Won Jung 1,2, Hyun-Jung
More informationChairs: John Lainchbury & Andrew Aitken. Elderly/Frailty
Frailty Elderly/Frailty Ralph Stewart Chairs: John Lainchbury & Andrew Aitken Elderly/Frailty Ralph Stewart Green Lane Cardiovascular Service and Cardiovascular Research Unit Auckland City Hospital 1 What
More informationFUNDACIÓN INVESTIGACIÓN BIOMÉDICA HOSPITAL UNIVERSITARIO GETAFE. Dr. Marta Checa Prof. Rodríguez Mañas MD, PhD Geriatrician H. U.
FUNDACIÓN INVESTIGACIÓN BIOMÉDICA HOSPITAL UNIVERSITARIO GETAFE Dr. Marta Checa Prof. Rodríguez Mañas MD, PhD Geriatrician H. U. Getafe (Madrid) Our research projects as Coordinator A comprehensive validation
More informationDo Elderly Men Have Increased Mortality Following Hip Fracture?
Do Elderly Men Have Increased Mortality Following Hip Fracture? Excess Mortality in Men Compared With Women Following a Hip Fracture. National Analysis of Comedications, Comorbidity and Survival. Kannegaard
More informationExtrapolating from fit to frail. Is it possible? How to assess the efficacy of preventive strategies in older subjects
Extrapolating from fit to frail. Is it possible? How to assess the efficacy of preventive strategies in older subjects Antonio Cherubini IRCCS-INRCA, Italy CONFLICT OF INTEREST DISCLOSURE I have no potential
More informationAldo P. Maggioni, Kees Van Gool, Nelly Biondi, Renato Urso, Niek Klazinga, Roberto Ferrari, Nikolaos Maniadakis and Luigi Tavazzi.
Appropriateness of prescriptions of recommended treatments in OECD health systems: findings based on the Long-Term Registry of the ESC on Heart Failure Aldo P. Maggioni, Kees Van Gool, Nelly Biondi, Renato
More informationWho is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers
HIV and migrants Julia del Amo has received research grants awarded to her institution from Companies BMS, Gilead, ViiV and epidemiology teaching fees from ViiV, Gilead and MSD Dr Julia del Amo National
More informationSurgery in Frail Elders. Emily Finlayson, MD, MS Department of Surgery University of California, San Francisco September, 2011
Surgery in Frail Elders Emily Finlayson, MD, MS Department of Surgery University of California, San Francisco September, 2011 What we re going to cover Mortality after surgery in the elderly Fact v Fantasy
More informationStudy period Total sample size (% women) 899 (37.7%) Warfarin Aspirin
Table S2 Sex- specific differences in oral anticoagulant prescription for stroke prevention in AF Total sample size (% women) Anticoagulant(s) studied Gage (2000) 1 Missouri, USA Discharged during 597
More informationFRAGILITÀ, DISABILITÀ E MALATTIE NELLO STUDIO PRO.V.A. Enzo Manzato (Padova)
FRAGILITÀ, DISABILITÀ E MALATTIE NELLO STUDIO PRO.V.A. Enzo Manzato (Padova) J Am Geriatr Soc 50, 1535, 2002 J Am Geriatr Soc 50, 1535, 2002 Odds Ratios for Activity of Daily Living Disability According
More informationCOGNITIVE IMPAIRMENT IN
COGNITIVE IMPAIRMENT IN THE HOSPITAL SETTING Professor Len Gray April 2014 Some key questions How common is cognitive impairment among hospitalised older patients? Which cognitive syndromes are associated
More informationNutrition to prevent and treat sarcopenia in older people
1 Nutrition to prevent and treat sarcopenia in older people Alfonso J. Cruz-Jentoft Hospital Universitario Ramón y Cajal Madrid, Spain Roma, 17 dicembre 2014 + The objective of Gerontology is not to increase
More informationSUNFRAIL. limits and potential of the Public Health Programme SUCCESS STORIES OF THE HEALTH PROGRAMME. Emilia-Romagna Region Mirca Barbolini & Team
limits and potential of the Public Health Programme SUCCESS STORIES OF THE HEALTH PROGRAMME SUNFRAIL Emilia-Romagna Region Mirca Barbolini & Team at the European Parliament, Brussels, 22 nd November 2017
More informationMeasles and rubella monitoring January 2015
Measles and rubella monitoring January 215 Reporting on January December 214 surveillance data and epidemic intelligence data to the end of January 215 Main developments Measles During the 12-month period
More informationImproving Healthcare Utilization in Injured Older Adults
Improving Healthcare Utilization in Injured Older Adults G ERIATRIC T R A U MA I N I T I AT I V E S AT S TA N F O R D H E A LT H C A R E J U LY 12, 2018 Objectives Background on Geriatric Trauma Population
More informationGERIATRIC TEACHING AND TRAINING IN EUROPE: Where are we? (part I)
GERIATRIC TEACHING AND TRAINING IN EUROPE: Where are we? (part I) Pr. Olivier Beauchet, MD, PhD Department of Neuroscience Geriatrics Division and Memory Clinic Angers University Hospital and School of
More informationStrokes After TAVR Reasons for Declining Frequency
Strokes After TAVR Reasons for Declining Frequency Samir Kapadia, MD Professor of Medicine Director, Cardiac Catheterization Laboratory Cleveland Clinic Disclosure NONE Second Generation Valves Newer
More informationTable Of Content. Outputs... 9
Table Of Content A european pilot network of reference centres in refractory epilepsy and epilepsy surgery... 2 Summary... 3 Coordinator, Leader contact and partners... 6 UNIVERSITAIR MEDISCH CENTRUM UTRECHT...
More informationJoint Programming in Neurodegenerative Disease Research (JPND)
Joint Programming in Neurodegenerative Disease Research (JPND) Building Alliances and Collaborations Prof. Philippe Amouyel, MD, PhD JPND Chair France Disclosure CEO of Fondation Plan Alzheimer Conference
More informationOn behalf of E-PILEPSY consortium Philippe Ryvlin (Lyon, France)
A European pilot network of reference centres in refractory epilepsy and epilepsy surgery On behalf of E-PILEPSY consortium Philippe Ryvlin (Lyon, France) Brussels, Written Declaration on Epilepsy! 6.000.000
More informationOBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP
OBSERVATIONAL Patient-centered observational analytics: New directions toward studying the effects of medical products Patrick Ryan on behalf of OMOP Research Team May 22, 2012 Observational Medical Outcomes
More informationInterventions to Improve Follow-up of Positive Results on Fecal Blood Tests
Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests Results of a systematic review, Kaiser experience, and implications for the Canton of Vaud Kevin Selby, M.D. Kevin.Selby@hospvd.ch
More informationESPEN Congress Leipzig Prognostic impact of body composition
ESPEN Congress Leipzig 2013 Prognostic impact of body composition Malnutrition and body composition changes in neurodegenerative diseases: as bad as in chronic diseases? E. Cereda (IT) Malnutrition and
More informationAs the proportion of the elderly in the
CANCER When the cancer patient is elderly, how do you weigh the risks of surgery? Marguerite Palisoul, MD Dr. Palisoul is Fellow in the Department of Obstetrics and Gynecology, Division of Gynecologic
More informationProspective Evaluation of the Eyeball Test for Assessing Frailty in Elderly Patients with Valvular Heart Disease
Prospective Evaluation of the Eyeball Test for Assessing Frailty in Elderly Patients with Valvular Heart Disease Background Frailty is a common occurrence in elderly patients Approximately half of the
More informationGlobal ACE Forum 2017
1 It s broke! Fix it! Challenging the status quo of geriatrics in acute care George A Heckman MD MSc FRCPC HTCP-1 Schlegel Research Chair in Geriatric Medicine Associate Professor, University of Waterloo
More informationAbert Borchette Conference Centre European Commission- Room 1C Bruxelles 5th April 2017
Abert Borchette Conference Centre European Commission- Room 1C Bruxelles 5th April 2017 Sunfrail Tool for the identification of Frailty and Multimorbidity Marcello Maggio UOC Clinica Geriatrica Dipartimento
More informationProject Meeting Prague
Project Meeting Prague IO1 Assessment 9.11.217 CHRISTINA PADBERG ON BEHALF OF FRANKFURT UAS Current Status Assessment matrix was fully evaluated Experts have been interviewed, Interviews were fully evaluated
More informationV. Roldán, F. Marín, B. Muiña, E. Jover, C. Muñoz-Esparza, M. Valdés, V. Vicente, GYH. Lip
PLASMA VON WILLEBRAND FACTOR LEVELS ARE AN INDEPENDENT RISK FACTOR ADVERSE EVENTS IN HIGH RISK ATRIAL FIBRILLATION PATIENTS TAKING ORAL ANTICOAGULATION THERAPY V. Roldán, F. Marín, B. Muiña, E. Jover,
More informationGiorgio VESCOVO MD PhD London
Sorrento, 13/5/2017 MISURARE LA COMPLESSITA DEL PAZIENTE: I DATI PRELIMINARI DELLO STUDIO COMPLIMED Giorgio VESCOVO MD PhD London FESC Il sottoscritto GIORGIO VESCOVO. ai sensi dell art. 3.3 sul Conflitto
More informationComprehensive Assessment of the Frail Older Patient
Comprehensive Assessment of the Frail Older Patient Executive Summary Comprehensive geriatric assessment (CGA) is a multidimensional and usually interdisciplinary diagnostic process designed to determine
More informationJosep Rodés-Cabau, MD, on behalf of the ARTE investigators
Versus Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve The ARTE Randomized Clinical Trial Josep Rodés-Cabau, MD, on behalf
More informationSupplementary Online Content
Supplementary Online Content Pincus D, Ravi B, Wasserstein D. Association between wait time and 30-day mortality in adults undergoing hip fracture surgery. JAMA. doi: 10.1001/jama.2017.17606 eappendix
More informationA Global perspective on Heart Failure: What needs to change? Martin R Cowie London, United Kingdom
A Global perspective on Heart Failure: What needs to change? Martin R Cowie London, United Kingdom Global perspective on heart failure: what needs to change? Martin R Cowie Professor of Cardiology National
More informationDALLA REAL LIFE INTERNAZIONALE A QUELLA ITALIANA: ESPERIENZE DAL CAMPO
RIVAROXABAN DALLA REAL LIFE INTERNAZIONALE A QUELLA ITALIANA: ESPERIENZE DAL CAMPO Giuseppe Camporese, MD Azienda Ospedaliera Universitaria di Padova Dipartimento di Scienze Cardiache, Toraciche e Vascolari
More informationTranscatheter Aortic Valve Replacement with a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients:
Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 1-Year Results from the SURTAVI Clinical Trial Nicolas M. Van
More informationAndrea Ungar, MD, PhD, FESC
TRATTAMENTO ENDOVASCOLARE DELLE VALVULOPATIE: NON SOLO LA TAVI Andrea Ungar, MD, PhD, FESC Dept. of Geriatrics and Intensive Care University of Florence, Italy EUGMS Special Interest Group on Valvular
More informationMEDICATIONS PRESCRIPTION AT HOSPITAL DISCHARGE IN PATIENTS WITH VALIDATED DIAGNOSIS OF DEMENTIA. Federica Edith Pisa University Hospital Udine
MEDICATIONS PRESCRIPTION AT HOSPITAL DISCHARGE IN PATIENTS WITH VALIDATED DIAGNOSIS OF DEMENTIA Federica Edith Pisa University Hospital Udine BACKGROUND Polypharmacy and psychotropic medication use are
More informationUrban Health Centres Europe (UHCE) Integrated social and health care to promote quality of life and independent living
E-mail: info@uhce.eu Website: http://uhce.eu/ Hein Raat, Carmen Franse, Elena Curtopassi Urban Health Centres Europe (UHCE) Integrated social and health care to promote quality of life and independent
More informationSubmission on the Draft National Clinical Practice Guidelines for Dementia in Australia
Submission on the Draft National Clinical Practice Guidelines for Dementia in Australia 4 June 2015 details Name of organisation Royal Australian College of General Practitioners () Postal Address Legal
More informationSUPPLEMENTARY INFORMATION
Table S1 Sex- specific differences in rate- control and rhythm- control strategies in observational studies Study region Study period Total sample size Sex- specific results Ozcan (2001) 1 Mayo Clinic,
More informationReal-World Insights from GARFIELD-AF Registry Presented at ESC Congress 2017
Real-World Insights from GARFIELD-AF Registry Presented at ESC Congress 2017 One of the aims of GARFIELD-AF is to assist physicians in their understanding of the risk of stroke in patients with atrial
More informationCurrent dietary habits in Europe far from plant based eating
Current dietary habits in Europe far from plant based eating Stefaan De Henauw Ghent University Department of Public Health Stefaan.dehenauw@ugent.be The menu What is plant based diet? Nutrition transition
More informationElections to EACVI Board and Sections
Application for the position: Councillor 1. Your Identity Title: Prof. Dr. Family Name(s): Van de Veire First Name(s): Nico R.L. Birth Date: 23th of June 1975 Type of address: Business/Home? Business Institute/Organisation:
More informationIL MANAGEMENT DEL DOLORE CRONICO NEL PAZIENTE ANZIANO Malattie, dolore cronico e sofferenza del paziente anziano
IL MANAGEMENT DEL DOLORE CRONICO NEL PAZIENTE ANZIANO Malattie, dolore cronico e sofferenza del paziente anziano Graziano Onder Centro Medicina dell Invecchiamento Università Cattolica del Sacro Cuore
More informationFrailty Assessment: Simplifying the Complex
Frailty Assessment: Simplifying the Complex Natalie Sanders, DO Internal Medicine, Geriatrics Rocky Mountain Geriatrics Conference 2017 U N I V E R S I T Y O F U T A H H E A L T H, 2 0 1 7 OBJECTIVES Define
More informationResults of Transfemoral Transcatheter Aortic Valve Implantation
Results of Transfemoral Transcatheter Aortic Valve Implantation Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division
More informationFor the SURTAVI Investigators
Neurological complications after transcatheter aortic valve implantation with a self-expanding bioprosthesis or surgical aortic valve replacement in patients at intermediate-risk for surgery A. Pieter
More informationSUNFRAIL PROJECT Understanding and Caring for Frailty and Multimorbidity. Speaker/Conference/Date
SUNFRAIL PROJECT Understanding and Caring for Frailty and Multimorbidity Speaker/Conference/Date ACKNOWLEDGEMENT This presentation is part of SUNFRAIL (project 664291), which has received funding from
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/22306 holds various files of this Leiden University dissertation. Author: Vochteloo, Anne Jochem Hendrik Title: Determinants of outcome in hip fracture
More informationEnd-of-life care in oxygen-dependent COPD and cancer: a national population-based study.
End-of-life care in oxygen-dependent COPD and cancer: a national population-based study. Ahmadi, Zainab; Lundström, Staffan; Janson, Christer; Strang, Peter; Emtner, Margareta; Currow, David C; Ekström,
More informationKomorbiditet og ortopædkirugi - erfaringer og viden. Benn Rønnow Duus, Ledende overlæge, Ortopædkirurgisk afdeling Bispebjerg Hospital
Komorbiditet og ortopædkirugi - erfaringer og viden Benn Rønnow Duus, Ledende overlæge, Ortopædkirurgisk afdeling Bispebjerg Hospital Kræft og komorbiditet alle skal have del i de gode resultater 1 Kræftens
More informationChirurgie Ziekenhuisgroep Twente Locatie Almelo. Disclosure presenter
Disclosure presenter The effectiveness of integrated orthogeriatric treatment on 1-year outcome in frail elderly withhip fracture E. Folbert, MANP, PhD Hospital Group, Almelo-Hengelo Rotterdam, 2018 august
More informationSupporting carers through the web: the road towards a new European web platform
Supporting carers through the web: the road towards a new European web platform Areti Efthymiou Eurocarers On behalf of the research team composed by: G. Lamura, F. Barbabella, C. Lancioni, R. Papa, A.
More informationCHL 5225 H Advanced Statistical Methods for Clinical Trials. CHL 5225 H The Language of Clinical Trials
CHL 5225 H Advanced Statistical Methods for Clinical Trials Two sources for course material 1. Electronic blackboard required readings 2. www.andywillan.com/chl5225h code of conduct course outline schedule
More informationCurrent levels and recent trends in health inequalities in the EU: Updates from the EU Report
Current levels and recent trends in health inequalities in the EU: Updates from the EU Report Anne Scott London Health Observatory Expert Working Group on Social Determinants and Health Inequalities Luxembourg,
More informationThe Community Assessment of Risk and Treatment Strategies (CARTS) Project. Professor D. William Molloy COLLAGE University College Cork, Ireland.
The Community Assessment of Risk and Treatment Strategies (CARTS) Project Professor D. William Molloy COLLAGE University College Cork, Ireland. Centre for Gerontology and Rehabilitation A time of limited
More informationTest and Learn Community Frailty Service for frail housebound patients and those living in care homes in South Gloucestershire
Test and Learn Community Frailty Service for frail housebound patients and those living in care homes in South Gloucestershire Introduction This document introduces South Gloucestershire Clinical Commissioning
More informationTrial clinici nell anziano: efficacy or effectiveness?
LA SPERIMENTAZIONE FARMACOLOGICA CLINICA IN ETÀ GERIATRICA Trial clinici nell anziano: efficacy or effectiveness? Graziano Onder Fondazione Universitaria Policlinico A. Gemelli Università Cattolica del
More informationMonthly measles and rubella monitoring report
SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data
More informationFrailty: Are we able to identify the older adult who is frail? A discussion on methods and limitations. Neil Pendleton University of Manchester
Frailty: Are we able to identify the older adult who is frail? A discussion on methods and limitations Neil Pendleton University of Manchester Frailty Foundation in observation by clinicians dealing with
More informationSaudi Arabia February Pr Michel KOMAJDA. Université Pierre et Marie Curie Hospital Pitié Salpétrière
Prevention of Cardiovascular events with Ivabradine: The SHIFT Study Saudi Arabia February 2011 Pr Michel KOMAJDA Université Pierre et Marie Curie Hospital Pitié Salpétrière Paris FRANCE Declaration Of
More informationGLORIA -AF REGISTRY PROGRAMME
GLORIA -AF REGISTRY PROGRAMME EXECUTIVE SUMMARY The approval of novel oral anticoagulants has changed prescribing patterns for stroke prevention in atrial fibrillation (AF) worldwide. 1 There is a need
More informationPre- Cardiac intervention. Dr. Victor Sim 16 th Oct 2014
Pre- Cardiac intervention Frailty assessment Dr. Victor Sim 16 th Oct 2014 Topics to cover Defining frailty Pathophysiology of frailty Are current pre-cardiac surgery assessment tools adequate? Why do
More informationExposure to potentially inappropriate medications among long-term care residents with cognitive impairment in Ontario:
Exposure to potentially inappropriate medications among long-term care residents with cognitive impairment in Ontario: Is there an association with frailty? Laura Maclagan, Jun Guan, Sima Gandhi, Colleen
More informationPredictors, incidence and outcomes of patients undergoing transcatheter aortic valve implantation complicated by stroke
Predictors, incidence and outcomes of patients undergoing transcatheter aortic valve implantation complicated by stroke From the CENTER-Collaboration Wieneke Vlastra, MD Heart Center, Amsterdam UMC, University
More informationIndication, Timing, Assessment and Update on TAVI
Indication, Timing, Assessment and Update on TAVI Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Starr- Edwards Mechanical
More informationBiological theory for the construct of intrinsic capacity to be used in clinical settings Matteo Cesari, MD, PhD
Biological theory for the construct of intrinsic capacity to be used in clinical settings Matteo Cesari, MD, PhD World Health Organization Geneva (Switzerland) December 1, 2016 World Health Organization.
More information